EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The development of non‐resorbable bone allografts: Biological background and clinical perspectives

Richard J Miron, Masako Fujioka-Kobayashi, Michael A Pikos, Toshiaki Nakamura, Takatomo Imafuji, Yufeng Zhang iD, Yukiya Shinohara, Anton Sculean, Yoshinori Shirakata iD

Periodontology 2000 · 2024-02 · 94 (1) · 161-179

DOI: 10.1111/prd.12551 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Periodontology 2000, online erschienen am 07.02.2024. Verfasst von Richard J Miron und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Periodontology, University of Bern, Bern, Switzerland. Hauptthemen laut MEDLINE: Bone Transplantation, Allografts. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bone grafts are typically categorized into four categories: autografts, allografts, xenografts, and synthetic alloplasts. While it was originally thought that all bone grafts should be slowly resorbed and replaced with native bone over time, accumulating evidence has in fact suggested that the use of nonresorbable xenografts is favored for certain clinical indications. Thus, many clinicians take advantage of the nonresorbable properties/features of xenografts for various clinical indications, such as contour augmentation, sinus grafting, and guided bone regeneration, which are often combined with allografts (e.g., human freeze‐dried bone allografts [FDBAs] and human demineralized freeze‐dried bone allografts [DFDBAs]). Thus, many clinicians have advocated different 50/50 or 70/30 ratios of allograft/xenograft combination approaches for various grafting procedures. Interestingly, many clinicians believe that one of the main reasons for the nonresorbability or low substitution rates of xenografts has to do with their foreign animal origin. Recent research has indicated that the sintering technique and heating conducted during their processing changes the dissolution rate of hydroxyapatite, leading to a state in which osteoclasts are no longer able to resorb (dissolve) the sintered bone. While many clinicians often combine nonresorbable xenografts with the bone‐inducing properties of allografts for a variety of bone augmentation procedures, clinicians are forced to use two separate products owing to their origins (the FDA/CE does not allow the mixture of allografts with xenografts within the same dish/bottle). This has led to significant progress in understanding the dissolution rates of xenografts at various sintering temperature changes, which has since led to the breakthrough development of nonresorbable bone allografts sintered at similar temperatures to nonresorbable xenografts. The advantage of the nonresorbable bone allograft is that they can now be combined with standard allografts to create a single mixture combining the advantages of both allografts and xenografts while allowing the purchase and use of a single product. This review article presents the concept with evidence derived from a 52‐week monkey study that demonstrated little to no resorption along with in vitro data supporting this novel technology as a “next‐generation” biomaterial with optimized bone grafting material properties.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone TransplantationAllograftsHumansAnimalsHeterograftsBone RegenerationBone SubstitutesBone Resorption

Stichwörter der Autor:innen

Bio‐Ossallograftanorganic bovine bone mineraldeproteinized bovine bone mineral

Substanzen

Bone Substitutes

Autor:innen und Institutionen

  • Department of Periodontology, University of Bern, Bern, Switzerland.
  • Department of Oral and Maxillofacial Surgery, School of Life Dentistry at Tokyo, The Nippon Dental University, Tokyo, Japan.
  • Pikos Institute, Tampa, Florida, USA.
  • Department of Periodontology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
  • Department of Oral Implantology, University of Wuhan, Wuhan, China.

ORCID-Profile: Yufeng Zhang, Yoshinori Shirakata

Zitieren

APA

Miron, R. J., Fujioka-Kobayashi, M., Pikos, M. A., Nakamura, T., Imafuji, T., Zhang, Y., Shinohara, Y., Sculean, A., & Shirakata, Y. (2024). The development of non‐resorbable bone allografts: Biological background and clinical perspectives. Periodontology 2000, 94(1), 161-179. https://doi.org/10.1111/prd.12551

Vancouver

Miron RJ, Fujioka-Kobayashi M, Pikos MA, Nakamura T, Imafuji T, Zhang Y, et al. The development of non‐resorbable bone allografts: Biological background and clinical perspectives. Periodontology 2000. 2024;94(1):161-179. doi:10.1111/prd.12551

BibTeX
@article{Miron2024,
  author = {Miron, Richard J and Fujioka-Kobayashi, Masako and Pikos, Michael A and Nakamura, Toshiaki and Imafuji, Takatomo and Zhang, Yufeng and Shinohara, Yukiya and Sculean, Anton and Shirakata, Yoshinori},
  title = {The development of non‐resorbable bone allografts: Biological background and clinical perspectives},
  journal = {Periodontology 2000},
  year = {2024},
  volume = {94},
  number = {1},
  pages = {161--179},
  doi = {10.1111/prd.12551}
}
Kostenlos starten →